Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherap. LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 13.50p 21,252 08:00:00
Bid Price Offer Price High Price Low Price Open Price
13.00p 14.00p 13.50p 13.50p 13.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -0.94 -0.71 16.0

Skinbiotherap. (SBTX) Latest News

More Skinbiotherap. News
Skinbiotherap. Takeover Rumours

Skinbiotherap. (SBTX) Share Charts

1 Year Skinbiotherap. Chart

1 Year Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

1 Month Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Intraday Skinbiotherap. Chart

Skinbiotherap. (SBTX) Discussions and Chat

Skinbiotherap. (SBTX) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Skinbiotherap. trades in real-time

Skinbiotherap. (SBTX) Top Chat Posts

DateSubject
15/12/2018
08:20
Skinbiotherap. Daily Update: Skinbiotherap. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherap. was 13.50p.
Skinbiotherap. has a 4 week average price of 13.13p and a 12 week average price of 13.13p.
The 1 year high share price is 29.50p while the 1 year low share price is currently 7.35p.
There are currently 118,708,494 shares in issue and the average daily traded volume is 141,089 shares. The market capitalisation of Skinbiotherap. is £16,025,646.69.
05/12/2018
11:50
bayetya: They certainly know how to reverse a rising share price...
20/11/2018
13:31
michaelmouse: I think you'll find it's a pointless RNS which regurgitates everything you already know except the fact that the first human study demonstrated that their "quackery" does SFA. The RNS is a desperate attempt to prop up the price of an massively overvalued company with zero revenues in a bear market. Even a whiff that results are not as good as hoped and the share price will rapidly sink below a penny.
08/11/2018
10:53
2350220: Ha ha, you sure wouldn't think so, if you just checked the share price! John
21/8/2018
23:01
ktfkoko: Wrong again, paranoia . What's your obsession with this Rayrac person , I'm not him I'm a her , and that's some insecurity you have . To be honest I am deleting my account as I told advfn there are too many rude arrogant people on this message board. Self Opinionated too. I will repeat , I liked the potential product , but the way the presentation was carried out made the share price drop like a stone , because she did not THINK about the impact of the way she presented the possible instability of the cream ( even though it wasn't the end product ) was going to have on the share price . She should get professional help with presentations . End of .
16/8/2018
13:58
mshilos: SBTX going below 20 p today and lower in the comings for reasons I explained in an earlier post below. In addition OPTI is now below £1 ...reason is as below : There is HUGE positive sentiment for OPTI and share price has soared recently on the back of this , but nothing more, no profit no HUGE contracts to report, no major news, etc, and NO PROFITS to report. They do have MASSIVE potential, if their LT plans are executed according to plan and they do have a great Founder/CEO. However, as a LT holder myself, since 27p I would expect the share price to fall to the 50-60 p levels before 2019 BUT to climb to over £2 in the next 2 years , if we keep moving in the right direction. It is only sentiment that is driven this share price at present, not profit, as there is no profit.IMO DYOR.
16/8/2018
12:06
mshilos: John in reply : I stand by my opinion that the clinical trial will now have to be delayed and there will need to be an RNS to confirm this once they know when it will take place. The share price will fall to the initial April 2017 price or lower until we have trial results. This is still in its infancy and far far away from a profit generating business but the potential is huge hence the recent share price price rise based on sentiment and potential alone. This RNS is not good news...it will drop more ...IMO. DYOR.
09/8/2018
08:23
bdog51: SBTX price seems to follow that of OPTI. Today OPTI is down because TW told his loyal HSR followers to top slice, hence somehow SBTX seems to have followed. Odd logic, I know!
02/8/2018
11:43
rafboy: Certainly think there is a company or two keeping a very close eye on SBTX. In 6 months the share price is likely to be 2 or 3 times the current share price assuming the human skin trials are a success. However, we have anecdotal evidence showing that the team at SBTX are currently using the cream. We also know it has been tested on human skin in the lab. I believe the likelihood is that the human skin trials will be a success and that a deal will follow on fairly quickly. Just my personal view.
28/7/2018
16:00
speccy1: The more I think about it, the more sense it makes to place the OPTI held shares with an institutional investor and pay a cash divi. If the sale includes a lock-in period, it not only safeguards the SBTX share price, but given many of the OPTI investors would use their divi to buy SBTX, it could significantly improve the share price. The problem could then be everyone fighting to spend their divi at once and a mass charge causing a short term spike. It would be a terrible dilemma whether to buy straight away or hang fire until the initial rush for shares has died down. First World problems :)
21/4/2018
20:46
onedayrodders: I posted this on OPTI board but will be of interest here .. Hey all, myself and Trotters were at the UK Investor show today and were chatting with SOH for quite a while.. I'm sure Trotters will be posting a few nuggets later but I know the SBTX divi is an Important issue many have asked about so here is what he said. They are absolutely aware and focused on making this as fair as possible by not allowing short term traders to benefit or damage either OPTI or SBTX share price. Options being discussed ... 1. Lock in period - Unlikely as regulators do not like this type of arrangement and view it as restricting the market. 2. Staggered benefit, for example, OPTI will give shareholders say 1000 SBTX shares and promise another 1000 shares the next year providing the first 1000 shares have not been sold. 3. Take advantage of increasing interest in Skinbiotix by selling a % of OPTI's stake in SBTX to by Institutional investors and delivering a SBTX cash divi. (Therefore delivering the SBTX divi promise, adding long term Institutional shareholders and removing volatility in the share price - my take) The qualifying for any divi, either shares or cash will be controlled by a record date and that cannot be a date in the past and will be from close of business on the day the divi details are announced. So they will be looking to time that towards the end of the day to allow the smallest window possible for the AIM trading vultures (my words not his !) That's from memory so hope I got it right (Trotters..correct me if I'm wrong) ODR
Skinbiotherap. share price data is direct from the London Stock Exchange
Your Recent History
LSE
SBTX
Skinbiothe..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181216 04:47:28